Canadian researchers have developed a microfluidic device that can help distinguish changes in red blood cells infected with the malaria parasite Plasmodium falciparum. The device has the potential to be modified for use in drug testing not only for malaria but diseases such as sickle cell anemia, according to a U.S. expert.

Related Summaries